Corporate News2021
- Dec. 07, 2021 NROlympus Sets Sights on Growth in Its Refocused Medical Business
- Dec. 02, 2021 NROlympus Selected for Inclusion in Dow Jones Sustainability World Index (DJSI World)
- Nov. 16, 2021 NRUpdate about cybersecurity incident in the U.S. – systems restored
- Nov. 12, 2021 NROlympus Launches Venture Capital Fund To Strengthen Medtech Leadership
- Oct. 19, 2021 NRUpdate: Investigation into cybersecurity incident ongoing
- Oct. 12, 2021 NRInvestigating potential cybersecurity incident affecting our IT system in the Americas
- Sep. 24, 2021 NROlympus to be listed the in the “Prime Market” segment on the TSE
- Sep. 14, 2021 InfoUpdate: Olympus Investigation Into Cybersecurity Incident Ongoing
- Sep. 11, 2021 InfoInvestigating potential cybersecurity incident affecting limited areas of our EMEA IT system
- Jul. 21, 2021 NROlympus to Support Endoscopic AI Diagnosis Education for Doctors in Thailand
- Jun. 01, 2021 NROlympus Agrees on Transfer of its IT Solutions Subsidiary Company
- May. 28, 2021 NROlympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
- May. 06, 2021 NROlympus Targets Carbon Neutrality by 2030
- Apr. 08, 2021 NROlympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business
- Mar. 23, 2021 NROlympus completes transfer of its regenerative medicine business Olympus RMS to Rohto Pharmaceutical
- Feb. 26, 2021 NROlympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
- Jan. 29, 2021 NROlympus launches supply chain automation in its largest logistics facility in Japan posting huge efficiency gains
- Jan. 28, 2021 NROlympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
- Jan. 04, 2021 NROlympus Completes Transfer of Imaging Business